N-(2(R)-2-(hydroxamidocarbonylmethyl)-4-methylpentanoyl)-L-tryptophan methylamide

matrix metallopeptidase 2 ; Mus musculus







11 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 25947075 Attenuation of EMT in RPE cells and subretinal fibrosis by an RAR-γ agonist. 2015 Jul 1
2 25336627 Podoplanin requires sialylated O-glycans for stable expression on lymphatic endothelial cells and for interaction with platelets. 2014 Dec 4 1
3 21193743 White matter damage and the effect of matrix metalloproteinases in type 2 diabetic mice after stroke. 2011 Feb 1
4 21857898 Matrix metalloproteinase-2 and -9 secreted by leukemic cells increase the permeability of blood-brain barrier by disrupting tight junction proteins. 2011 1
5 19276073 Matrix metalloproteinase-2-deficient fibroblasts exhibit an alteration in the fibrotic response to connective tissue growth factor/CCN2 because of an increase in the levels of endogenous fibronectin. 2009 May 15 1
6 18790756 Metastasis is strongly reduced by the matrix metalloproteinase inhibitor Galardin in the MMTV-PymT transgenic breast cancer model. 2008 Sep 2
7 18837800 Matrix metalloproteinase 2 improves the transplanted adipocyte survival in mice. 2008 Oct 1
8 17569779 Complex regulation of pulmonary inflammation and fibrosis by CCL18. 2007 Aug 1
9 17065436 Matrix metalloproteinases expressed by astrocytes mediate extracellular amyloid-beta peptide catabolism. 2006 Oct 25 2
10 12591918 Elevated glucose inhibits VEGF-A-mediated endocardial cushion formation: modulation by PECAM-1 and MMP-2. 2003 Feb 17 1
11 12453184 In vitro migration of melanoblasts requires matrix metalloproteinase-2: implications to vitiligo therapy by photochemotherapy. 2002 Dec 1